Lymphoma, Non-Hodgkin

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +86 more
Jan 23, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Germany, Puerto Rico, United States (Lenalidomide, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +114 more
Jan 11, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (TAK-981, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +58 more
Dec 7, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +3 more
  • lisocabtagene maraleucel
  • Gilbert, Arizona
  • +40 more
Apr 22, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +21 more
Oct 26, 2021

Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)

Completed
  • Lymphoma, Non-Hodgkin
  • HIV Infections
  • Bleomycin sulfate
  • +9 more
  • Los Angeles, California
  • +13 more
Oct 27, 2021

Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

Completed
  • Lymphoma, B-Cell
  • +2 more
  • Autologous transplantation using rituxan/BEAM
  • Autologous transplantation using Bexxar/BEAM
  • New Haven, Connecticut
  • +35 more
Oct 21, 2021

Family Study of Lymphoproliferative Disorders

Recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Aug 30, 2021

    Lymphoma Epidemiology of Outcomes Cohort Years 6-10

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
      • Miami, Florida
      • +7 more
      Aug 20, 2021

      Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

      Completed
      • Hodgkin Disease
      • Lymphoma, Non-Hodgkin
      • Survey
      • Rochester, New York
        University of Rochester Medical Center
      Mar 4, 2021

      Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)

      Completed
      • Lymphoma, Non-Hodgkin
      • Fullerton, California
      • +51 more
      May 26, 2020

      Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

      Completed
      • Lymphoma, Large-Cell, Anaplastic
      • Lymphoma, Non-Hodgkin
      • brentuximab vedotin
      • Birmingham, Alabama
      • +21 more
      Feb 2, 2017

      Lymphoma, Non-Hodgkin Trial in United States (Fludarabine, Velcade, Rituximab)

      Terminated
      • Lymphoma, Non-Hodgkin
      • Bloomington, Indiana
      • +10 more
      Aug 30, 2016

      Lymphoma, Non-Hodgkin, MALT Lymphoma Trial in Boston, Rochester (Fludarabine, Rituximab)

      Completed
      • Lymphoma, Non-Hodgkin
      • MALT Lymphoma
      • Boston, Massachusetts
      • +3 more
      Jul 28, 2016

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

      Terminated
      • Lymphoma, Large B-Cell, Diffuse
      • Lymphoma, Non-Hodgkin
      • Birmingham, Alabama
      • +65 more
      Feb 6, 2015

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40)

      Completed
      • Lymphoma, Large B-Cell, Diffuse
      • Lymphoma, Non-Hodgkin
      • Birmingham, Alabama
      • +13 more
      Dec 17, 2014

      Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

      Completed
      • Carcinoma, Renal Cell
      • Lymphoma, Non-Hodgkin
      • Birmingham, Alabama
      • +8 more
      Dec 17, 2014

      Lymphoma, Non-Hodgkin Trial in Canada, United States (Granulocyte colony-stimulating factor plus plerixafor, Granulocyte

      Completed
      • Lymphoma, Non-Hodgkin
      • Granulocyte colony-stimulating factor plus plerixafor
      • Granulocyte colony-stimulating factor plus placebo
      • Phoenix, Arizona
      • +31 more
      Feb 10, 2014

      Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (G-CSF Plus Plerixafor)

      Completed
      • Lymphoma, Non-Hodgkin
      • Multiple Myeloma
      • G-CSF Plus Plerixafor
      • Little Rock, Arkansas
      • +7 more
      Feb 10, 2014

      Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (G-CSF and plerixafor)

      Completed
      • Lymphoma, Non-Hodgkin
      • Multiple Myeloma
      • G-CSF and plerixafor
      • Duarte, California
      • +4 more
      Feb 10, 2014

      Lymphoma, Non-Hodgkin Trial in United States (TRAIL-R1 mAb (TRM-1; HGS-ETR1))

      Completed
      • Lymphoma, Non-Hodgkin
      • TRAIL-R1 mAb (TRM-1; HGS-ETR1)
      • Rochester, Minnesota
      • +6 more
      Aug 1, 2013

      A Study of Patients With AIDS Syndrome

      Completed
      • Sarcoma, Kaposi
      • +3 more
        • Menlo Park, California
        • +22 more
        Sep 11, 2008